Searched for
AUROBINDO PHARMA INVESTMENT
Quant Mid Cap Fund adds Adani Energy and 4 others, exits Paytm and 3 more stocks in MayQuant Mid Cap Fund, managed by Sandeep Tandon, has strategically adjusted its portfolio in May. The fund added Adani Energy and four other ...16 Jun, 2026, 10.55 AM IST- Ahead of Market: 10 things that will decide stock market action on TuesdayIndian equities rallied sharply as an interim US-Iran peace framework eased geopolitical concerns and pushed oil prices lower. Improved inf...15 Jun, 2026, 09.15 PM IST
- Flexi cap fund inflows halve to Rs 5,175 crore in May after record April. Is this profit booking or a buying opportunity?Flexi cap fund inflows dropped 49% in May to Rs 5,175 crore after April’s record surge, reflecting broader moderation across equity categor...15 Jun, 2026, 10.20 AM IST
- HDFC Defence Fund adds Tata Motors, reduces exposure in MTAR Technologies and 1 other in MayHDFC Defence Fund added Tata Motors to its portfolio in May while trimming holdings in MTAR Technologies and Rishabh Instruments. The fund ...13 Jun, 2026, 11.49 AM IST
- Quant Small Cap Fund raises stake in Adani Enterprises and 8 others, trims in Aurobindo Pharma and 4 moreQuant Small Cap Fund increased exposure to Adani Enterprises and eight other stocks in May while reducing holdings in Aurobindo Pharma and ...12 Jun, 2026, 01.55 PM IST
- Stocks in news: Rajesh Exports, Lenskart, Suzlon Energy, Aurobindo Pharma, Tata MotorsIndian markets saw volatility and closed lower on Wednesday. Key companies are in focus due to significant developments. SoftBank reduced i...04 Jun, 2026, 06.43 AM IST
- Bernstein initiates coverage on 6 pharma stocks, cites 3 major tailwinds for healthcare sectorBernstein has initiated coverage on six Indian pharma stocks, with Zydus Lifesciences as its top choice. The brokerage sees strong future g...22 May, 2026, 04.40 PM IST
- Laurus Labs adds Rs 40,150 crore to investors' wealth in a year with 120% rally. Buy, hold or book profits?Laurus Labs has significantly boosted investor wealth, adding over Rs 40,000 crore in a year with a 120% stock rally. Driven by business im...19 May, 2026, 10.34 AM IST
- Pharma, NBFCs see fresh mutual fund buying in AprilIndian fund managers focused on defensive stocks in April. Pharmaceuticals saw increased investment due to opportunities like the semagluti...14 May, 2026, 06.26 AM IST
- JioBlackRock Flexi Cap Fund exits 3 AMC stocks, HAL, and 13 others in AprilJioBlackRock Mutual Fund’s Flexi Cap Fund completely exited 17 stocks in April, including AMC companies and Hindustan Aeronautics, while ad...11 May, 2026, 12.51 PM IST
- Buy capital goods on dips, stay cautious on IT and consumption: Sudip BandyopadhyayMarket expert Sudip Bandyopadhyay outlines investment strategies across key sectors. He sees opportunities in State Bank of India and a gen...09 May, 2026, 11.15 AM IST
- Small & midcaps rally! Wockhardt, Coforge, other stocks surge up to 14%. Do you own any?Smallcap and midcap stocks surged on Wednesday, outperforming broader market indices with gains of around 1% each. This rally was fueled by...06 May, 2026, 11.56 AM IST
- Aurobindo Pharma's Rs 800 cr buyback closes this week: Should you tender shares?Aurobindo Pharma has initiated a share buyback program valued at Rs 800 crore, set to remain open until April 29. The company aims to reacq...27 Apr, 2026, 04.13 PM IST
- Stocks in news: SBI Life, Trent, Tata Investment, HCL Tech, Suzlon EnergyIn today's trade, shares of SBI Life, Trent, Tata Investment, HCL Tech, Suzlon Energy among others will be in focus due to various news dev...22 Apr, 2026, 06.27 AM IST
- Accumulate Aurobindo Pharma, target price Rs 550: Prabhudas LilladherAurobindo Pharma Ltd., incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 28151.42 Crore) operating in Pharma...17 Nov, 2022, 10.05 AM IST
- Buy Aurobindo Pharma, target price Rs 600: Centrum BrokingAurobindo Pharma Ltd., incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 28842.83 Crore) operating in Pharma...16 Nov, 2022, 09.24 AM IST
- Outperform Aurobindo Pharma., target Rs 910: Credit SuisseAurobindo Pharma added $450 mn in market cap on Dolutegravir (DTG) approval.26 Sep, 2016, 03.01 PM IST
Load More
